EBMT 2018 | Vaccines for the treatment of CMV in stem cell transplant recipients

Genovefa Papanicolaou

Speaking from the 2018 European Group for Blood and Marrow Transplantation (EBMT) Annual Meeting, held in Lisbon, Portugal, Genovefa Papanicolaou, MD, from Memorial Sloan Kettering Cancer Center, New York, NY, speaks about novel vaccines that are being developed for the treatment of cytomegalovirus (CMV) in cancer patients receiving stem cell transplants.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter